| | Baseline | Switch | 3 months | 3 years | 4 years |
|---|
> 20/40 | 34.5% | 58.6% | 69.5% | 62.5% | 58.9% |
20/50–20/100 | 52.9% | 36.8% | 31.8% | 31.8% | 37.5% |
< 20/200 | 12.6% | 5.7% | 2.3% | 5.7% | 3.8% |
- Percentage of eyes with VA greater than 20/40, 20/50–20/100, and 20/200 or worse. From baseline to 3 months, the percentage of patients with 20/40 vision increased from 34.5 to 65.9%, while patients with 20/50–20/100 and 20/200 or worse vision steadily decreased. From 3 months to 4 years, the percentage of patients with 20/40 vision was in large part maintained from 65.9 to 58.9%, with the proportion of patients with 20/50–20/100 vision changing correspondingly
